Clinical Trial Update: Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for adipose-derived stromal vascular fraction cells in Parkinson's disease (Phase 1/Phase 2; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease
• Parkinson Disease and Parkinsonism

Drugs mentioned

• Adipose-derived stromal vascular fraction cells

Snippet

Sponsor: Samuel Vilchez, PhD | Conditions: Idiopathic Parkinson Disease, Parkinson's Disease and Parkinsonism | Phase 1, Phase 2 | Status: COMPLETED